IL33 and non-small cell lung carcinoma: However, this was likely due to the wider variation in recorded IL-33 levels in addition to a larger proportion of NSCLC samples (42.9%, compared to 4–12% in controls, respectively) that was below the limit of detection of the IL-33 ELISA kit (Figure 2E).